Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08 Settembre 2023 - 2:30PM
Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering
drug-eluting biomatrix products, today announced that Dr. Randy
Mills, President and Chief Executive Officer, will present at the
H.C. Wainwright 25th Annual Global Investment Conference. The
presentation will take place in New York on Wednesday, September
13, 2023, at 2:30 pm ET.
A live webcast of the presentation can be
accessed by visiting the Company’s Events & Presentations
webpage or by clicking here. A replay will be available on the
Company’s website following the event.
Institutional investors interested in meeting
with management during the conference may reach out to their H.C.
Wainwright representative.
About Elutia
Elutia develops and commercializes biologic
products to improve compatibility between medical devices and the
patients who need them. With a growing population in need of
implantable technologies, Elutia’s mission is humanizing medicine
so patients can thrive without compromise. For more information,
visit www.Elutia.com.
Investors:Matt SteinbergFINN
Partnersmatt.steinberg@finnpartners.com
Grafico Azioni Elutia (NASDAQ:ELUT)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Elutia (NASDAQ:ELUT)
Storico
Da Nov 2023 a Nov 2024